CL2011000085A1 - Procedimiento para la produccion de una composicion de glicosaminoglicano, que comprende someter a cromatografia un homogeneizado de material de un animal marino no mamifero usando una matriz cromatografica en la forma de un absorbedor de membrana. - Google Patents
Procedimiento para la produccion de una composicion de glicosaminoglicano, que comprende someter a cromatografia un homogeneizado de material de un animal marino no mamifero usando una matriz cromatografica en la forma de un absorbedor de membrana.Info
- Publication number
- CL2011000085A1 CL2011000085A1 CL2011000085A CL2011000085A CL2011000085A1 CL 2011000085 A1 CL2011000085 A1 CL 2011000085A1 CL 2011000085 A CL2011000085 A CL 2011000085A CL 2011000085 A CL2011000085 A CL 2011000085A CL 2011000085 A1 CL2011000085 A1 CL 2011000085A1
- Authority
- CL
- Chile
- Prior art keywords
- homogenate
- production
- marine animal
- chromatographic matrix
- membrane absorber
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 title abstract 4
- 239000006096 absorbing agent Substances 0.000 title abstract 2
- 239000012504 chromatography matrix Substances 0.000 title abstract 2
- 239000000463 material Substances 0.000 title abstract 2
- 239000012528 membrane Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000004587 chromatography analysis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0066—Isolation or extraction of proteoglycans from organs
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Peptides Or Proteins (AREA)
Abstract
Procedimiento para la producción de una composición de glicosaminoglicano, que comprende someter a cromatografía un homogeneizado de material de un animal marino no mamífero que contiene glicosaminoglicano usando una matriz cromatográfica en la forma de un absorbedor de membrana; composición y uso de glicosaminoglicanos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0812919.9A GB0812919D0 (en) | 2008-07-15 | 2008-07-15 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2011000085A1 true CL2011000085A1 (es) | 2011-07-01 |
Family
ID=39722304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2011000085A CL2011000085A1 (es) | 2008-07-15 | 2011-01-14 | Procedimiento para la produccion de una composicion de glicosaminoglicano, que comprende someter a cromatografia un homogeneizado de material de un animal marino no mamifero usando una matriz cromatografica en la forma de un absorbedor de membrana. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110288283A1 (es) |
| EP (1) | EP2310421A1 (es) |
| JP (1) | JP2011528058A (es) |
| CN (1) | CN102124032A (es) |
| AU (1) | AU2009272491A1 (es) |
| BR (1) | BRPI0915926A2 (es) |
| CA (1) | CA2730607A1 (es) |
| CL (1) | CL2011000085A1 (es) |
| GB (1) | GB0812919D0 (es) |
| WO (1) | WO2010007387A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108179162A (zh) * | 2018-01-16 | 2018-06-19 | 浙江海洋大学 | 一种低分子量肝素的制备方法 |
| BR112023022331A2 (pt) * | 2021-05-12 | 2023-12-26 | Nexeos Diagnostics Inc | Métodos de fabricação de um composto de heparina de alto peso molecular |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3244214A1 (de) * | 1982-11-30 | 1984-05-30 | B. Braun Melsungen Ag, 3508 Melsungen | Verfahren zur reinigung und fraktionierung von heparin |
| EP0337327A1 (en) * | 1988-04-09 | 1989-10-18 | Bioiberica, S.A. | Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin |
| DE19538625C2 (de) * | 1995-10-17 | 1999-08-12 | Sartorius Gmbh | Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie |
| DE19711083C2 (de) * | 1997-03-18 | 1999-04-29 | Sartorius Gmbh | Vorrichtung und Verfahren für die adsorptive Stofftrennung mit Adsorptionsmembranen |
| TW422712B (en) * | 1997-04-01 | 2001-02-21 | Wako Pure Chem Ind Ltd | Liquid test components separation method and equipment thereof |
| EP1114060B1 (en) * | 1998-09-15 | 2003-06-11 | NIZO food research | Process for producing peptides from biological fluids and peptides obtainable by said process |
| US6812221B2 (en) * | 2000-11-21 | 2004-11-02 | The Texas A&M University System | FGF-affinity chromatography |
| WO2002076475A2 (en) * | 2001-03-23 | 2002-10-03 | Bioparken As | Glycosaminoglycan anticoagulants derived from fish |
| EP1401571B1 (en) * | 2001-06-22 | 2006-05-10 | Argonide Corporation | Sub-micron filter |
| DE10236664B4 (de) * | 2002-08-09 | 2016-05-12 | Sartorius Stedim Biotech Gmbh | Verfahren und Vorrichtung zur adsorptiven Stofftrennung |
| GB0229696D0 (en) * | 2002-12-20 | 2003-01-29 | Amersham Biosciences Ab | Separation medium |
| JP2008538181A (ja) * | 2005-03-30 | 2008-10-16 | ネオス テクノロジーズ インコーポレイテッド | 昆虫細胞系において増殖させたペプチドを生産するための製造方法 |
| GB0509433D0 (en) * | 2005-05-09 | 2005-06-15 | Uni For Milj Og Biovitenskap | Method |
-
2008
- 2008-07-15 GB GBGB0812919.9A patent/GB0812919D0/en not_active Ceased
-
2009
- 2009-07-15 AU AU2009272491A patent/AU2009272491A1/en not_active Abandoned
- 2009-07-15 US US13/002,765 patent/US20110288283A1/en not_active Abandoned
- 2009-07-15 JP JP2011517996A patent/JP2011528058A/ja active Pending
- 2009-07-15 CA CA2730607A patent/CA2730607A1/en not_active Abandoned
- 2009-07-15 BR BRPI0915926A patent/BRPI0915926A2/pt not_active IP Right Cessation
- 2009-07-15 CN CN2009801283700A patent/CN102124032A/zh active Pending
- 2009-07-15 WO PCT/GB2009/001784 patent/WO2010007387A1/en not_active Ceased
- 2009-07-15 EP EP09784737A patent/EP2310421A1/en not_active Withdrawn
-
2011
- 2011-01-14 CL CL2011000085A patent/CL2011000085A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010007387A1 (en) | 2010-01-21 |
| GB0812919D0 (en) | 2008-08-20 |
| US20110288283A1 (en) | 2011-11-24 |
| JP2011528058A (ja) | 2011-11-10 |
| EP2310421A1 (en) | 2011-04-20 |
| AU2009272491A1 (en) | 2010-01-21 |
| CN102124032A (zh) | 2011-07-13 |
| CA2730607A1 (en) | 2010-01-21 |
| BRPI0915926A2 (pt) | 2015-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HN2009000379A (es) | Anticuerpo especifico prlr y sus usos | |
| CL2008002076A1 (es) | Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades. | |
| BRPI0820497A2 (pt) | Processo para produção de etanol utilizando celulose com enzimas geradas através de cultura do estado sólido. | |
| SG149759A1 (en) | Media for affinity chromatography | |
| BRPI0915728A2 (pt) | composição enzimática, processo para preparar a composição, uso da composição enzimática, e, composição detergente. | |
| CL2008002319A1 (es) | Compuestos derivados de pirrolopirimidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer. | |
| ATE493081T1 (de) | Faserverstärktes verbundmaterial | |
| CL2012003625A1 (es) | Una composicion acuosa que contiene bromhexina, en donde la composicion tiene una cantidad de azucar-alcoholes inferior a 10 g referida a 100 ml de la composicion; y su uso para la terapia secretorica en enfermedades broncopulmonares agudas y cronicas. | |
| UA108199C2 (uk) | АНТИТІЛО ПРОТИ α5β1 І ЙОГО ЗАСТОСУВАННЯ | |
| MX276615B (es) | Proceso para preparar prepolimeros de poliuretano actinicamente curables que contienen alofanato con resistencia incrementada. | |
| BRPI0813680A2 (pt) | AGENTES DE iRNA, COMPOSIÇÃO FARMACÊUTICA COMPREENDENDO OS MESMOS, BEM COMO SEU USO. | |
| BRPI0814420A2 (pt) | composição, e, uso de álcool alcoxilado. | |
| BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
| BRPI0923915A2 (pt) | endoglucanases fúngicas, sua produção e uso | |
| CL2008000873A1 (es) | Compuestos derivados de pirrolidin amidas; composicion farmaceutica que comprende dichos compuestos; y su uso para tratar trombosis. | |
| CR20110553A (es) | Terapia complementaria contra el cáncer | |
| CL2008002558A1 (es) | Compuestos derivados de catecolamina sustituidas, composicion farmaceutica, util para tratar parkinson, huntington, psicosis, impotencia e insuficiencia renal, entre otras enfermedades. | |
| CL2008002486A1 (es) | Comprimido divisible de liberacion modificada que comprende glicazida, un derivado de celulosa elegido entre: hmc, hec, hpc y/o hpmc y un aglutinante elegido entre: maltodextrina, polividona o hpmc; uso para tratar diabetes. | |
| AR074985A1 (es) | Bacterias etanologenicas y su uso en la produccion de etanol | |
| BRPI0810399A2 (pt) | Composto, composição farmacêutica que o contém e uso do mesmo | |
| ATE532814T1 (de) | Neue ammonium-polyurethan- und/oder polycarbonat- verbindungen | |
| BRPI0810560A2 (pt) | Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida. | |
| CL2008002532A1 (es) | Procedimiento de sintesis de un derivado de pirido-[2,1-a]isoquinolina; formas cristalinas de dichos compuestos; y su uso para tratar diabetes, diabetes mellitus, trastorno de la intolerancia a la glucosa. | |
| BRPI0918870A2 (pt) | método para produzir álcool, método para produzir hidrogênio ou gás de síntese usando o método para produzir álcool, e álcool. | |
| ES2572368T3 (es) | Tratamiento de la artrosis |